Neurology 2002;59:S7-S14
© 2002 American Academy of Neurology
| Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.
|
Animal models of epileptogenesis
H. Steve White, PhD
From the Anticonvulsant Screening Project, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT.
Address correspondence and reprint requests to Dr. H. Steve White, Anticonvulsant Screening Project, Dept. Pharmacology and Toxicology, University of Utah, 20 S. 2030 E., Room 408, Salt Lake City, UT 84112; e-mail: swhite{at}hsc.utah.edu
Advances in our understanding of the molecular biology of human epileptogenesis and secondary hyperexcitability have resulted in part from the development and characterization of animal models of mesial temporal lobe epilepsy, trauma-induced epilepsy, and age-specific models of febrile seizures and neonatal hypoxia-induced seizures. Each of these models displays similarities to and differences from their human counterparts and will undoubtedly prove useful for evaluating novel therapies aimed at preventing the development, or halting the progression, of epilepsy or insult-induced secondary hyperexcitability. This article briefly reviews those models that most closely parallel human mesial temporal lobe epilepsy, trauma-induced epilepsy, febrile seizures, and hypoxia-induced seizures. Particular attention is paid to the underlying pathology, the presence or absence of a latent period, and development of spontaneous seizures.
This article has been cited by other articles:
|
|
|
|
 
A. K. Sharma, G. H. Searfoss, R. Y. Reams, W. H. Jordan, P. W. Snyder, A. Y. Chiang, R. A. Jolly, and T. P. Ryan
Kainic Acid-induced F-344 Rat model of Mesial Temporal Lobe Epilepsy: Gene Expression and Canonical Pathways
Toxicol Pathol,
October 1, 2009;
37(6):
776 - 789.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Huang, M. C. Walker, and M. M. Shah
Loss of Dendritic HCN1 Subunits Enhances Cortical Excitability and Epileptogenesis
J. Neurosci.,
September 2, 2009;
29(35):
10979 - 10988.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Chauviere, N. Rafrafi, C. Thinus-Blanc, F. Bartolomei, M. Esclapez, and C. Bernard
Early Deficits in Spatial Memory and Theta Rhythm in Experimental Temporal Lobe Epilepsy
J. Neurosci.,
April 29, 2009;
29(17):
5402 - 5410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Sharma, W. H. Jordan, R. Y. Reams, D. G. Hall, and P. W. Snyder
Temporal Profile of Clinical Signs and Histopathologic Changes in an F-344 Rat Model of Kainic Acid-induced Mesial Temporal Lobe Epilepsy
Toxicol Pathol,
December 1, 2008;
36(7):
932 - 943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Singh, J. F. Otto, E. Jill Dahle, C. Pappas, J. D. Leslie, A. Vilaythong, J. L. Noebels, H. Steve White, K. S. Wilcox, and M. F. Leppert
Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization
J. Physiol.,
July 15, 2008;
586(14):
3405 - 3423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Sharma, R. Y. Reams, W. H. Jordan, M. A. Miller, H. L. Thacker, and P. W. Snyder
Mesial Temporal Lobe Epilepsy: Pathogenesis, Induced Rodent Models and Lesions
Toxicol Pathol,
December 1, 2007;
35(7):
984 - 999.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Hu, A. Janke, S. Ortler, H-P Hartung, C. Leder, B. C. Kieseier, and H. Wiendl
Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies
Neurology,
January 23, 2007;
68(4):
277 - 282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Dube, C. Richichi, R. A. Bender, G. Chung, B. Litt, and T. Z. Baram
Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis
Brain,
April 1, 2006;
129(4):
911 - 922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P A Csurhes, A-A Sullivan, K Green, M P Pender, and P A McCombe
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
J. Neurol. Neurosurg. Psychiatry,
October 1, 2005;
76(10):
1431 - 1439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Gorson, A. A. Amato, and A. H. Ropper
Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy
Neurology,
August 24, 2004;
63(4):
715 - 717.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D'Ambrosio, J. P. Fairbanks, J. S. Fender, D. E. Born, D. L. Doyle, and J. W. Miller
Post-traumatic epilepsy following fluid percussion injury in the rat
Brain,
February 1, 2004;
127(2):
304 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yang, B. J. Beyer, J. F. Otto, T. P. O'Brien, V. A. Letts, H. S. White, and W. N. Frankel
Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold
Hum. Mol. Genet.,
May 1, 2003;
12(9):
975 - 984.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
